Glenmark Pharma rallies on Germany marketing nod

Share prices of Glenmark Pharmaceuticals rose over 3 percent early Monday as its subsidiary Glenmark Arzneimittel secured marketing authorization for a dry powder inhaler in Germany.

The drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.

For more information on stock tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co

Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research

Posted in: Indian Market Tips